Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Net Cash Flow (2022 - 2025)

Core Laboratories (CLB) has 4 years of Net Cash Flow data on record, last reported at -$5.6 million in Q3 2025.

  • For Q3 2025, Net Cash Flow fell 247.1% year-over-year to -$5.6 million; the TTM value through Sep 2025 reached $4.2 million, down 14.47%, while the annual FY2024 figure was $4.0 million, 1410.71% up from the prior year.
  • Net Cash Flow reached -$5.6 million in Q3 2025 per CLB's latest filing, down from $9.1 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $9.9 million in Q2 2023 and bottomed at -$9.6 million in Q3 2023.
  • Average Net Cash Flow over 4 years is $729307.7, with a median of $857000.0 recorded in 2023.
  • Peak YoY movement for Net Cash Flow: plummeted 296.85% in 2023, then surged 1525.12% in 2025.
  • A 4-year view of Net Cash Flow shows it stood at $1.7 million in 2022, then plummeted by 188.21% to -$1.5 million in 2023, then tumbled by 54.88% to -$2.3 million in 2024, then crashed by 139.92% to -$5.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were -$5.6 million in Q3 2025, $9.1 million in Q2 2025, and $2.9 million in Q1 2025.